Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433550
Status:
COMPLETED
Last Update Posted:
2017-08-24
First Post:
2007-02-08
Brief Title:
Irinotecan Oxaliplatin and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Organization Data
Organization:
Alliance for Clinical Trials in Oncology
Class:
OTHER
Study ID:
NCCTG-N0543
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |
| National Cancer Institute NCI | NIH |
| Pfizer | INDUSTRY |